drugset / Trial / NCT03712371
Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients
NaSingle-groupOpen-labelTreatment
Summary
This study will examine the utility of chitosan for reduction of blood or tissue levels of AGEs in patients with prostate cancer who are clinically stable on androgen-deprivation therapy.
Timeline
- Start
- 2019-01-16
- Primary completion
- 2020-07-02
- Completion
- 2021-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | POLIGLUSAM | Other / unclassified | 500 mg | — |
| Subject | POLIGLUSAM | Other / unclassified | 1000 mg | — |
| Subject | POLIGLUSAM | Other / unclassified | 1500 mg | — |
| Subject | POLIGLUSAM | Other / unclassified | 2000 mg | — |